Genomics Services
Precision works with you to select the most appropriate genomics platforms for your project’s goals, providing comprehensive genomic characterization of any tissue or cell type. This includes profiling rare cells such as circulating tumor cells (CTCs), progenitor cells, as well as circulating tumor DNA (ctDNA).
Our genomics lab services range from assay development to validation at both preclinical and clinical stages and can include utilization of pre-developed panels and assays or development of custom panels.
Genomics solutions for preclinical research or any clinical endpoint
-
Explore
NGS
Services including RNA-seq, whole exome sequencing, and targeted DNA/RNA sequencing utilizing both Illumina and Thermo-Fisher NGS platforms
NGS
Services including RNA-seq, whole exome sequencing, and targeted DNA/RNA sequencing utilizing both Illumina and Thermo-Fisher NGS platforms -
Explore
ddPCR
Advanced ddPCR applications from preclinical to clinical assays including gene therapy viral shedding and CAR-T biodistribution
ddPCR
Advanced ddPCR applications from preclinical to clinical assays including gene therapy viral shedding and CAR-T biodistribution -
Explore
qPCR
Multiple platforms including the QuantStudio™ 12k Flex with OpenArray™ plates for rapid, multiplexed screening of dozens of genes and samples in a single run
qPCR
Multiple platforms including the QuantStudio™ 12k Flex with OpenArray™ plates for rapid, multiplexed screening of dozens of genes and samples in a single run -
Explore
NanoString
Panels that enable the simultaneous analysis of up to 800 genes; ideal for projects where highly multiplexed analysis is needed, such as oncology and autoimmune therapeutic development
NanoString
Panels that enable the simultaneous analysis of up to 800 genes; ideal for projects where highly multiplexed analysis is needed, such as oncology and autoimmune therapeutic development -
Explore
FISH/ISH
Development of multiplex FISH/ISH assays to detect abnormalities in a range of tissues, including hematological and solid organ tumors
FISH/ISH
Development of multiplex FISH/ISH assays to detect abnormalities in a range of tissues, including hematological and solid organ tumors -
Explore
Single-Cell Sequencing
End-to-end single-cell sequencing solutions utilizing the 10x Genomics Chromium system and Illumina NGS platform
Single-Cell Sequencing
End-to-end single-cell sequencing solutions utilizing the 10x Genomics Chromium system and Illumina NGS platform
-
Explore
MassARRAY
Comprehensive genotyping solutions using the MassARRAY® system for high-throughput analysis of genetic variations, ideal for applications in pharmacogenomics, oncology, and genetic research
MassARRAY
Comprehensive genotyping solutions using the MassARRAY® system for high-throughput analysis of genetic variations, ideal for applications in pharmacogenomics, oncology, and genetic research
Learn more about our Genomics Solutions
Additional specialty lab services
-
Explore
Liquid Biopsy Analysis
Obtain a detailed molecular view into patient biology with a range of liquid biopsy analysis technologies, including our proprietary ApoStream platform which can isolate and enrich for circulating tumor cells for downstream analysis.
Liquid Biopsy Analysis
Obtain a detailed molecular view into patient biology with a range of liquid biopsy analysis technologies, including our proprietary ApoStream platform which can isolate and enrich for circulating tumor cells for downstream analysis.
-
Explore
Bioanalytical Testing
Get bioanalytical support for your biologic, cell therapy, gene therapy, or companion diagnostics program from the globally-recognized leaders in immunogenicity testing.
Bioanalytical Testing
Get bioanalytical support for your biologic, cell therapy, gene therapy, or companion diagnostics program from the globally-recognized leaders in immunogenicity testing.
-
Explore
Immune Monitoring
Leverage sophisticated multiplex flow cytometry approaches and other technologies, including our proprietary Epiontis ID platform, to characterize the immune cells in your samples and understand their impact on disease and patient biology.
Immune Monitoring
Leverage sophisticated multiplex flow cytometry approaches and other technologies, including our proprietary Epiontis ID platform, to characterize the immune cells in your samples and understand their impact on disease and patient biology.